Consistently, clinical studies show increased IL-1β level in the serum and inflamed colonic tissues of IBD patients, and IL-1β levels are correlated well with the severity of intestinal inflammation and disease activity (23–26). This evidence concerns the gene IL1B and inflammatory response.